Investigation of Compatible Stability of Xingnaojing Injection Based on HPLC Fingerprint and Principal Component Analysis

Meng-nan ZHOU; Ya-jing WANG; Yi ZHANG; Li-na SHANG; Hai-ning ZHAO; Hui-shu SHI; Ya-nan WANG; Jin-ling LI

doi:10.13422/j.cnki.syfjx.20191047

您当前的位置：

首页 >

文章列表页 >

Investigation of Compatible Stability of Xingnaojing Injection Based on HPLC Fingerprint and Principal Component Analysis

Pharmacy and Processing | 更新时间：2021-02-09

- Investigation of Compatible Stability of Xingnaojing Injection Based on HPLC Fingerprint and Principal Component Analysis
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 19, Pages: 80-86(2019)
- 作者机构：
  
  天津中医药大学　现代中药发现与制剂技术教育部工程研究中心，天津　 301617
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20191047
  CLC： R22; R24; R28; C37; R94
- Received：17 November 2018，
  
  Published Online：28 January 2019，
  
  Published：05 October 2019
- 稿件说明：
移动端阅览
Meng-nan ZHOU, Ya-jing WANG, Yi ZHANG, et al. Investigation of Compatible Stability of Xingnaojing Injection Based on HPLC Fingerprint and Principal Component Analysis[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(19): 80-86.
DOI：

Meng-nan ZHOU, Ya-jing WANG, Yi ZHANG, et al. Investigation of Compatible Stability of Xingnaojing Injection Based on HPLC Fingerprint and Principal Component Analysis[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(19): 80-86. DOI： 10.13422/j.cnki.syfjx.20191047.

摘要

目的：

考察醒脑静注射液与9种联用药物配伍的稳定性，为该药物的临床安全应用提供参考。

方法：

根据临床使用情况，将醒脑静注射液分别与9种联用药物进行配伍并置于室内避光条件下和光照条件下6 h，考察配伍溶液的外观性状变化，并采用相似性评价及主成分分析方法对配伍溶液的HPLC指纹图谱进行分析。

结果：

醒脑静注射液与吡拉西坦氯化钠注射液等9种药物配伍后外观均未发生明显变化。相似度评价结果显示，醒脑静注射液与吡拉西坦氯化钠注射液等9种药物配伍0 h，放置6 h及光照6 h的指纹图谱相似度均>0.98。主成分分析结果显示，9组配伍溶液聚为两类；其中与吡拉西坦氯化钠注射液等8种药物的配伍溶液聚为一类，且配伍后醒脑静注射液的特征成分相对峰面积均无明显变化；与丹参川芎嗪注射液的配伍溶液聚为一类，配伍0，6 h后醒脑静注射液的某些特征成分相对峰面积增大，光照6 h后更加明显。

结论：

醒脑静注射液与吡拉西坦氯化钠注射液等8种药物的配伍稳定性良好，与丹参川芎嗪注射液配伍则存在稳定性问题，提示临床应用时需注意其配伍问题。

Abstract

Objective:

To investigate the compatible stability of Xingnaojing injection in combination with 9 common medicines

and to provide a reference for clinical application of this injection.

Method:

According to the clinical application

Xingnaojing injection was mixed with 9 common medicines and placed in the room under dark and light conditions for 6 h. The appearance of compatible solutions was observed

and the HPLC fingerprint was analyzed by similarity evaluation and principal component analysis(PCA).

Result:

There were no significant changes in the appearance of compatibility of Xingnaojing injection and 9 common medicines

including piracetam and sodium chloride injection

sodium chloride injection and others. The similarities of fingerprint among compatibility of Xingnaojing injection and 9 common medicines were >0.98 at 0 h of compatibility

6 h of placement and 6 h of illumination. The results of PCA showed that 9 groups of compatible solutions were clustered into 2 categories

the compatibility of Xingnaojing injection and 8 groups including piracetam and sodium chloride injection clustered into one category

and the relative peak areas of the characteristic components of Xingnaojing injection did not change significantly after compatibility

the compatibility of Xingnaojing injection and Danshen Chuanxiongqin injection clustered into another category

the relative peak areas of some characteristic components of Xingnaojing injection increased after compatibility of 0 h and 6 h

and it was more obvious after 6 h of illumination.

Conclusion:

The compatibility of Xingnaojing injection and 8 common medicines including piracetam and sodium chloride injection has good stability

while the compatibility has stability problems after Xingnaojing injection mixed with Danshen Chuanxiongqin injection. It is suggested that clinical attention should be paid to their compatibility and rational combination of medicines.

关键词

Keywords

references

王妙菊，刘芳，赵荣生．醒脑静注射液临床应用评价 [J]．陕西中医学院学报， 2009 ， 32 ( 5 )： 84 - 85 ．

FANG J , YANG B , GE Z , et al . Single standard substance for the determination of nine volatile components in the distillate of Fructus Gardeniae and Radix Curcumae(an intermediate of Xingnaojing Injection) [J]. J Sep Sci , 2017 , 40 ( 20 ): 3946 - 3957 .

中华人民共和国卫生部，国家食品药品监督管理局，国家中医药管理局．关于进一步加强中药注射剂生产和临床使用管理的通知 [EB/OL]． http://samr.cfda.gov.cn/WS01/CL0056/35302.html ， 2008-12-24 / 2019-01-04 ．

吴琳娜，李芸，刘俐．洛赛克针剂与醒脑静注射液存在配伍禁忌 [J]．中国实用护理杂志， 2012 ， 28 ( 23 )： 33 ．

曾慧婷，沙秀秀，宿树兰，等．不同产地丹参茎叶UPLC指纹图谱与化学模式识别研究 [J]．中草药， 2017 ， 48 ( 4 )： 767 - 772 ．

杨立新，冯伟红，夏伯候，等．醒脑静注射液HPLC特征图谱研究 [J]．中国中药杂志， 2016 ， 41 ( 9 )： 1640 - 1645 ．

王立强，王思玲，苏德森．醒脑静注射液质量控制研究 [J]．中成药， 2004 ， 26 ( 4 )： 289 - 291 ．

刘颖，王青，王放，等．苦碟子注射液HPLC指纹图谱与化学模式识别分析 [J]．中国药学杂志， 2013 ， 48 ( 24 )： 2097 - 2101 ．

徐彤，黄萌萌，陈家进，等．安宫牛黄丸HPLC指纹图谱及化学模式识别分析 [J]．中国实验方剂学杂志， 2017 ， 23 ( 20 )： 14 - 19 ．

潘玄玄，宋粉云，林秀莲，等．沉香化气丸的UPLC指纹图谱与化学模式识别 [J]．中国实验方剂学杂志， 2017 ， 23 ( 19 )： 105 - 110 ．

杨园珍，王雅琪，胡恋琪，等．不同产地葛根与粉葛的HPLC指纹图谱及其多成分化学模式识别分析 [J]．中国实验方剂学杂志， 2019 ， 25 ( 4 )： 162 - 166 ．

李强，朱晓红，王强，等．三黄颗粒HPLC指纹图谱与化学模式识别分析 [J]．解放军药学学报， 2015 ， 31 ( 3 )： 194 - 198 ．

谭乐俊，王萌，朱彦．中药注射剂的不良反应研究进展 [J]．中国中药杂志， 2014 ， 39 ( 20 )： 3889 - 3898 ．

张兰杰，谢程．中药注射剂在医院使用中存在的问题及对策分析 [J]．长春中医药大学学报， 2016 ， 32 ( 6 )： 1257 - 1259 ．

李学林，李伟霞，赵娅，等．丹红注射液与胞磷胆碱钠注射液在2种常用溶媒中的配伍稳定性 [J]．中国实验方剂学杂志， 2017 ， 23 ( 3 )： 6 - 9 ．

Gad H A , El-Ahmady S H , Abou-Shoer M I , et al . Application of chemometrics in authentication of herbal medicines: a review [J]. Phytochem Anal , 2013 , 24 ( 1 ): 1 - 24 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Establishment of UPLC Fingerprint and Quantitative Analysis of Multi-components of Shengyutang

HPLC Fingerprint Analysis of Substance Benchmark of Xiao Chengqitang

Fingerprint Analysis of Bupleurum chinense Roots from Different Origins by UPLC/Q-TOF-MS

HPLC Fingerprint Analysis of Notopterygii Rhizoma et Radix with Different Commercial Specifications

Fingerprint of Epimedium wushanense Based on Principal Component,Factor and Cluster Analysis

Related Author

Yu-qing ZHANG

An WU

Ting ZOU

Zhi-feng ZHAO

Shao-hua XIAN

Yu XIANG

Xu-guang HU

Yan MENG

Related Institution

School of Traditional Chinese Medicine， Guangdong Pharmaceutical University

Sinopharm Group Dezhong （Foshan） Pharmaceutical Co. Ltd.

Key Laboratory of Modern Preparation of Traditional Chinese Medicine （TCM），Ministry of Education，Jiangxi University of TCM

Jiangxi University of Traditional Chinese Medicine

School of Chinese Materia Medica, Beijing University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰